Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis by Langley, R.G., Rich, P., Menter, A., Krueger, G., Goldblum, O., Dutronc, Y., Zhu, B., Wei, H., Cameron, G.S., Heffernan, M.P.

Get full text

Features that define clinical severity of ulcerative pyoderma gangrenosum – a Delphi consensus study of experts and patients on behalf of the United States Medical Dermatology Soci... by Pimentel, M.A., Li, M.M., Noe, M.H., Latour, E., Seminario-Vidal, L., Greiling, T., Shinkai, K., Hamilton, A., Alavi, A., Bolognia, J.L., Cowen, E.W., Dominguez, A., Fernandez, A.P., Fivenson, D., Huang, W.W., Madigan, L.M., Mauskar, M., Means, A.D., Nelson, C.A., Patsatsi, A., Pugliese, D., Rojek, N.W., Rosenbach, M., Smith, G.P., Swerlick, R.A., Heffernan, M.P., Mostaghimi, A., Loayza, A.G. Ortega

Get full text

A high level of clinical response is associated with improved patient-reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab by Edson-Heredia, E., Banerjee, S., Zhu, B., Maeda-Chubachi, T., Cameron, G.S., Shen, W., Heffernan, M.P., Gordon, K.B., Leonardi, C.L.

Get full text

Sigmoid volvulus: a 10-year-audit by Connolly, S, Brannigan, A E, Heffeman, E, Hyland, J M P

Get full text

Report of the Council for the session 2003-2004 by Grieve, Andy

Get full text